down arrow

Senores Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0RB801010
  • NSEID: SENORES
  • BSEID: 544319
INR
550.80
34.6 (6.7%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 5.95 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Senores Pharmaceuticals Ltd stock-summary
stock-summary
Senores Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
Senores Pharmaceuticals Limited was originally incorporated as "Senores Pharmaceuticals Private Limited" through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to "Senores Pharmaceuticals Limited" upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Swapnil Jatin Shah (7.72%)

Highest Public shareholder

Icici Prudential Equity Savings Fund (2.94%)

Individual Investors Holdings

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
10 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,537 Cr (Small Cap)

stock-summary
P/E

76.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.15

stock-summary
Return on Equity

15.40%

stock-summary
Price to Book

11.64